https://www.selleckchem.com/pr....oducts/curcumin-anal
The COVID-19 pandemic has impacted healthcare environment. To determine the impact of the pandemic on self-reported outcomes in patients with adrenal insufficiency (AI). Prospective longitudinal survey study at 2 tertiary centers. Patients with AI. Patient-centered questionnaire. Depression Anxiety Stress Scales-21, Short Form-36, and AI self-management. Of 342 patients, 157 (46%) had primary AI, 109 (32%) had secondary AI, and 76 (22%) had glucocorticoid-induced AI. When compared to prepandemic, daily glucocorticoid
Like
Comment
Share
